UniProt | Protein Name |
---|---|
Q9NRR6 |
|
GO Term | Evidence Code | PMID |
---|---|---|
biological_process | ||
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ||
phosphatidylinositol-3-phosphate biosynthetic process | ||
phosphatidylinositol biosynthetic process |
|
|
negative regulation of translation |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0070115 | Meckel syndrome 1 | |
DOID:0080212 | polycystic kidney disease 4 | |
DOID:0090053 | episodic kinesigenic dyskinesia 1 | |
DOID:0110123 | Bardet-Biedl syndrome 1 | |
DOID:0110124 | Bardet-Biedl syndrome 2 | |
DOID:0110125 | Bardet-Biedl syndrome 3 | |
DOID:0110126 | Bardet-Biedl syndrome 4 | |
DOID:0110127 | Bardet-Biedl syndrome 5 | |
DOID:0110128 | Bardet-Biedl syndrome 6 | |
DOID:0110129 | Bardet-Biedl syndrome 7 |
HPO ID | HPO Term |
---|---|
HP:0000752 | Hyperactivity |
HP:0000864 | Abnormality of the hypothalamus-pituitary axis |
HP:0001105 | Retinal atrophy |
HP:0001161 | Hand polydactyly |
HP:0001162 | Postaxial hand polydactyly |
HP:0001249 | Intellectual disability |
HP:0001250 | Seizure |
HP:0001251 | Ataxia |
HP:0001252 | Hypotonia |
HP:0001256 | Intellectual disability, mild |
Disease ID | Disease Name |
---|---|
ORPHA:75858 |
|
ORPHA:475 |
|
OMIM:213300 |
|
ORPHA:220493 |
|
OMIM:610156 |
|
ORPHA:1454 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
118313688 | SCOMX33339 | ||
117031766 | RHIFE22142 | ||
100218296 | TAEGU06803 | ||
101814688 | FICAL06189 | ||
103239625 | CHLSB02884 | ||
104669671 | RHIRO02026 | ||
114588931 | PODMU25694 | ||
107552629 | SINGR74247 | ||
107587653 | SINGR23674 | ||
106845556 | EQUAS29286 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024